Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 31, 2026
Business Overview: Global nutrition company selling weight management, targeted nutrition, energy, sports, fitness, and outer nutrition products through a network of independent members. Operations are organized into five geographic regions: North America, Latin America, EMEA, Asia Pacific, and China.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $1,317.2 | $1,221.7 |
| Gross Profit | $1,026.1 | $956.5 |
| Operating Income | $138.4 | $122.8 |
| Net Income Attributable to Herbalife | $61.9 | $50.4 |
| Diluted EPS | $0.57 | $0.49 |
| Operating Cash Flow | $113.8 | $0.2 |
| Cash and Cash Equivalents (End of Period) | $451.2 | $351.0 |
| Total Debt (Carrying Value) | $1,991.1 | $1,992.6 |
| Working Capital | $230.0 | $131.8 |
Margins: Gross margin was 77.9% (down 40 bps from 78.3%); Operating margin was 10.5% (up 40 bps from 10.1%).
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.8% ($95.5M) driven by a 4.1% increase in sales volume, 3.2% favorable price impact, and 2.4% favorable foreign currency fluctuations.
- Profitability: Net income increased 22.8% ($11.5M), primarily due to higher gross profit ($69.6M increase), $5.5M in China government grant income, and lower net interest expense ($5.2M decrease).
- Expense Increases: General and administrative expenses rose $31.1M (driven by labor/benefits and India GST expenses); Selling expenses rose $28.4M due to higher sales volume.
- Cash Flow: Operating cash flow surged to $113.8M from $0.2M, largely due to favorable changes in working capital (specifically other current liabilities and inventories) and higher net income.
- Segment Performance:
- Asia Pacific: Sales up 17.3% (driven by India, up 31.6% due to GST rate reduction).
- Latin America: Sales up 17.1% (driven by currency and price increases).
- China: Sales down 12.0% due to a 17.6% volume decrease.
- North America: Sales down 2.7% due to volume decline and weather impacts.
Guidance, Outlook, Risks, and Unusual Items
- Subsequent Debt Refinancing (April 2026): The company issued $800M of 7.750% Senior Secured Notes due 2033 and amended its credit facility. Proceeds were used to repay the 2024 Term Loan B and redeem the 2029 Secured Notes. A preliminary loss on extinguishment of debt of approximately $95 million is expected to be recorded in Q2 2026.
- Acquisitions:
- Bioniq: Agreed to acquire assets of UK-based personalized supplements company for $55M base consideration plus up to $95M in contingent payments (closed April 2026).
- Pruvit/Pro2col: Completed asset acquisitions in Q2 2025; contingent milestone payments remain outstanding.
- Restructuring & Technology: The 2024 Restructuring Program is complete. The "Technology Realignment Program" is ongoing with $11.5M incurred to date; expected total cost is $15M.
- Risks & Contingencies:
- Tax Matters: Significant ongoing tax assessments in Brazil (ICMS), Mexico (VAT), and India (Income Tax/GST). The company does not believe a loss is probable for most but has posted surety bonds/letters of credit totaling over $150M related to Brazil.
- Legal: Class action lawsuit regarding distributor misclassification in California; product liability claims (insured with $10M deductible).
- Geopolitical: Exposure to inflation, foreign exchange volatility, and trade tensions (tariffs). Russia operations suspended due to inventory depletion.
Investor Verification Checklist
- Debt Extinguishment Charge: Verify the final accounting impact of the April 2026 refinancing and the expected $95M loss on extinguishment in Q2 2026 results.
- China Sales Trend: Monitor the 12% sales decline in China and the effectiveness of digital initiatives and loyalty programs to reverse volume contraction.
- Tax Contingencies: Review the status of Brazil and India tax assessments, specifically the potential for additional accruals if legal outcomes shift.
- India GST Impact: Assess the sustainability of the 31.6% sales growth in India following the September 2025 GST rate reduction.
- Working Capital Volatility: Analyze the drivers of the $99M favorable change in operating assets/liabilities to determine if the Q1 cash flow surge is repeatable.